Abstract
Objective: Immunosuppressive agents are known to interfere with T and/or B lymphocytes, which are required to mount an adequate serologic response. Therefore, we aim to investigate the antibody response to SARS-CoV-2 in liver transplant (LT) recipients after COVID-19.
Design: Prospective multicentre case-control study, analysing antibodies against the nucleocapsid protein, spike (S) protein of SARS-CoV-2 and their neutralising activity in LT recipients with confirmed SARS-CoV-2 infection (COVID-19-LT) compared with immunocompetent patients (COVID-19-immunocompetent) and LT recipients without COVID-19 symptoms (non-COVID-19-LT).
Results: Overall, 35 LT recipients were included in the COVID-19-LT cohort. 35 and 70 subjects fulfilling the matching criteria were assigned to the COVID-19-immunocompetent and non-COVID-19-LT cohorts, respectively. We showed that LT recipients, despite immunosuppression and less symptoms, mounted a detectable antinucleocapsid antibody titre in 80% of the cases, although significantly lower compared with the COVID-19-immunocompetent cohort (3.73 vs 7.36 index level, p<0.001). When analysing anti-S antibody response, no difference in positivity rate was found between the COVID-19-LT and COVID-19-immunocompetent cohorts (97.1% vs 100%, p=0.314). Functional antibody testing showed neutralising activity in 82.9% of LT recipients (vs 100% in COVID-19-immunocompetent cohort, p=0.024).
Conclusions: Our findings suggest that the humoral response of LT recipients is only slightly lower than expected, compared with COVID-19 immunocompetent controls. Testing for anti-S antibodies alone can lead to an overestimation of the neutralising ability in LT recipients. Altogether, routine antibody testing against separate SARS-CoV-2 antigens and functional testing show that the far majority of LT patients are capable of mounting an adequate antibody response with neutralising ability.
Keywords: COVID-19; immune response; liver transplantation.
【저자키워드】 COVID-19, immune response, Liver transplantation, 【초록키워드】 SARS-CoV-2, Antibody testing, immune response, antibody, SARS-COV-2 infection, Antibody Response, Immunosuppression, Symptoms, immune, nucleocapsid protein, Protein, Cohort, Testing, Humoral response, Prospective, Patient, Liver transplantation, multicentre, SARS-CoV-2 antigen, COVID-19 symptoms, liver, Serologic response, liver transplant, SARS-CoV-2 antigens, Antibody titre, Neutralising activity, Immunosuppressive agents, case-control study, criteria, humoral, COVID-19 symptom, B lymphocytes, recipients, subject, no difference, cohorts, recipient, significantly lower, anti-S antibody, controls, neutralising ability, detectable, required, functional, majority, less, interfere, assigned, expected, the antibody response, mounted, with COVID-19, 【제목키워드】 liver, recipient,